Global Summit on
Toxicology and Applied Pharmacology
Dubai, UAE | March 03-05, 2025
Dear
Colleagues,
Apex
Global Meetings is delighted to announce and cordially invite all the
participants across the globe to attend the Global Summit on
Toxicology and Applied Pharmacology (GSTAP2025) on March 3-5, 2025, in Dubai,
UAE. The theme of the conference is "Advancing
Health and Safety: Exploring Innovations and Challenges in Toxicology and
Pharmacology." Scientific Tracks designed for this
conference will enable the attendees and participants to learn extremes.
GSTAP2025
aims to gather the renowned scientists, young and brilliant researchers,
academicians, healthcare professionals, business delegates, and exceptional
student communities across the globe under one roof and organize a healthy
discussion so that the researchers and authors can present their work at the
conference.
GSTAP2025's objective is to provide a comprehensive global forum for experts
and participants from academia to exchange ideas and present the results of
on-going research in the most state-of-the-art areas. It will be hosting a
forum of plenary, keynote, invited lectures, and oral and poster presentations.
We
accept that this gathering will be an exceptionally remunerating, instructive,
and collaborative occasion for the attendees.
We
look forward to your valuable presence at GSTAP2025 on March 3–5, 2025, in
Dubai, UAE.
Regards,
Sammi
R| Event Manager
GSTAP2025
Apex
Global Meetings
Email:
secretary@toxicologysummit.org
Contact:
91-8977610040
Analytical Toxicology
Animal Testing Methods
Pharmacovigilence
Aquatic Toxicology
Behavior Toxicology
Behavioral pharmacology
Biochemical pharmacology
Cardiotoxicity
Cardiovascular Pharmacology
Clinical application of systems
Computational Toxicology
Developmental and reproductive toxicology
Drug discovery, development and evaluation
Drug Toxicity
Drugs of abuse
Ecotoxicology
Emerging in-vitro models for the toxicity studies
Experimental and Toxicologic Pathology
Food Toxicology
Forensic Toxicology
Experimental and Toxicologic Pathology
Psychopharmacology
Regulatory Affairs
Pharmacogenetics
Pharmacological Chemistry
Intracellular signalling
Pharmacodynamics
Pharmacokinetics
Pharmaco economics.
The
Toxicology Drug Screening Market size is estimated at USD 14.51 billion in
2024, and is expected to reach USD 22.09 billion by 2029, growing at a CAGR of
8.77% during the forecast period (2024-2029).
The
emergence of the COVID-19 pandemic had a significant impact on the market
studied. Due to the onset of COVID-19, the need for vaccines and effective
treatment development increased. This further increased the extensive use of
toxicological screening methods in drug development. According to an article published
in the PMC journal in July 2022, various government authorities recommended
nonclinical safety studies such as efficacy, biodistribution, and toxicology
studies prior to proceeding to First-in-human (FIH) clinical trials for
COVID-19 vaccine candidate consisting of a novel product type for which no
prior nonclinical and clinical data were available prior. Such instances show
that the demand for toxicology testing increased during the pandemic, fueling
the market growth, and the studied market is likely to witness growth during
the forecast period.
The
studied market is driven by three major factors such as increasing research and
development (R&D) expenditure, technological advancements in toxicity
screening, and rising demand for toxicological drug screening.
Chronic
diseases are major factors that are fueling the demand for drug discovery and
increase in R&D expenditure. Cancer and heart diseases are the major cause
of healthcare burden globally. According to the 2022 update by 'Cancer Research
UK,' if the recent trends in the incidence of major cancers and population
growth are consistent, the new cancer cases will reach 27.5 million worldwide
by 2040. With the rise in disease incidence, the major companies are
concentrating on developing new drugs and therapeutics, followed by a demand
generation for toxicology drug screenings for the same. Hence, the studied
market is expected to witness growth over the forecast period.
The
applications of toxicity testing are set to increase with advances in biotechnology
and pharmaceuticals, resulting in a demand for the same. Several emerging
fields and techniques are providing new insights into understanding biological
responses to chemicals in human tissues. Furthermore, there is an increase in
pharmaceutical R&D spending globally. According to the IFPMA's 2021 report,
the annual R&D spending by the biopharmaceutical industry is 7.3 times
higher than that of the aerospace and defense industries, 6.5 times more than
the chemicals industry, and 1.5 times more than the software and computer
services industry. The source above also mentioned that the biopharmaceutical
industry spent USD 196,000 million in 2021, and it is expected to increase to
USD 213,000 million by 2024. Thus, the increasing R&D in the biopharmaceutical
industry for pharmaceutical product development is garnering the toxicology
screening of the drug products, fueling the studied market growth.
In Vivo
toxicology market worldwide is projected to grow by US$2.6 billion, driven by a
combined growth of 6.6%. Instruments, one of the segments analysed and sized
during this study, show the potential to grow at over 6.3%. The shifting
dynamics supporting this growth make it crucial for businesses in this space to
stay abreast of the dynamic pulse of the market. Poised to succeed in over
US$2.5 billion by the year 2025, instruments can usher in healthy gains, adding
important momentum to international growth. Representing the developed world,
the U.S. can maintain a 5.6% growth momentum among Europe that continues to
stay a crucial part of the world economy, FRG can add over US$90.5 million to
the region's size and clout within the next five to six years. Over US$78.7
million of projected demand within the region can come back from the remainder
of European markets.
Groups of three or more will receive a Special discount by using the group code. If you have any queries, please contact us at or call
secretary@toxicologysummit.org